Blood-based NfL
A biomarker for differential diagnosis of parkinsonian disorder
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 22, 2016
- Accepted in final form November 15, 2016
- First Published February 8, 2017.
Article Versions
- Previous version (February 8, 2017 - 12:40).
- You are viewing the most recent version of this article.
Author Disclosures
- Oskar Hansson, MD, PhD,
- Shorena Janelidze, PhD,
- Sara Hall, MD,
- Nadia Magdalinou, MD,
- Andrew J. Lees, MD, PhD,
- Ulf Andreasson, PhD,
- Niklas Norgren, PhD,
- Jan Linder, MD, PhD,
- Lars Forsgren, MD, PhD,
- Radu Constantinescu, MD, PhD,
- Henrik Zetterberg, MD, PhD,
- Kaj Blennow, MD, PhD;
- For the Swedish BioFINDER study
- Oskar Hansson, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
The research support is given in the manuscript.
NONE
NONE
The support is listed in the manuscript.
NONE
NONE
NONE
NONE
NONE
NONE
- Shorena Janelidze, PhD,
NONE
NONE
(1) Lund University, MultiPark, funding for travel to conference
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Kockska foundation, Lead investigator, 2015 (2) Kockska foundation, Lead investigator, 2016
NONE
NONE
NONE
NONE
NONE
NONE
- Sara Hall, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nadia Magdalinou, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andrew J. Lees, MD, PhD,
Britannia, UCB phrama, Teva, Lundbeck, BIAL, Roche, Nordiclnfu Care, NeuroDerm, Decision Resources
NONE
Britannia, UCB pharma, Teva, Lundbeck, BIAL, Roche, Nordiclnfu Care, NeuroDerm, Decision Resources
2006 Archivas de Nevropsiquiatria (Brazil) 1995-03 Co-Editor in Chief, Movement Disorders Journal and Historical Section Editor 1994-98 Founder Editor, Behavioural Neurology 1994- Neurologia Espana 1994-00 Revista Neurologica, Argentina 1994-95 European Journal of Neurology 1993- Revue Neurologique 1993-03 Brain 1991-95 Journal Neurology, Neurosurgery & Psychiatry 1989-95 Journal of Neurology 1988-95 Journal of Neural Transmission
NONE
NONE
Institute of Neurology, UCL
Britannia Pharmaceutical, BIAL Portela
NONE
NONE
NONE
NONE
NONE
NONE
Frances and Renee Hock Fund
NONE
NONE
NONE
NONE
NONE
NONE
- Ulf Andreasson, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Stiftelsen f?r Gamla Tj?narinnor (2) Alzheimerfonden (3) Demensfonden
NONE
NONE
NONE
NONE
NONE
NONE
- Niklas Norgren, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
I am employed by UmanDiagnostics AB (been working for UmanDiagnostics since 2006)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jan Linder, MD, PhD,
(1) AbbVie
NONE
NONE
NONE
NONE
NONE
NONE
(1) AbbVie
NONE
NONE
NONE
NONE
NONE
Ume? University
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lars Forsgren, MD, PhD,
NONE
NONE
NONE
Acta Neurologica Scandinavica, member of the editorial board.2001 up to now (2016)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Swedish Medical Research Council, K2013-62X-15224-10- 4, PI, 2013-2016
NONE
1. The Swedish Parkinsons disease association, 699/14, PI, 2014-2015 and 2015-2016
NONE
NONE
NONE
NONE
NONE
NONE
- Radu Constantinescu, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Henrik Zetterberg, MD, PhD,
NONE
NONE
NONE
Journal of Alzheimer's Disease, Associate Editor Alzheimer's & Dementia, Associate Editor DADM, Associate Senior Editor
NONE
NONE
NONE
NONE
NONE
HZ is co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg.
NONE
NONE
(1) The Swedish Research Council (K2010-63P-21562-01-4, K2011-61X-20401-05-6); (2) Swedish State Support for Clinical Research (ALFGBG-144341); (3) VINNOVA; (4) the Knut and Alice Wallenberg Foundation; (5) the European Research Council; and (6) Frimurarestiftelsen
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kaj Blennow, MD, PhD;
Dr Blennow has served at advisory boards or as a consultant for Alzheon, Eli Lilly, Fujirebio Europe, IBL International, and Roche Diagnostics.
NONE
NONE
NONE
NONE
NONE
NONE
Novartis
NONE
Co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg
NONE
NONE
The Research Council, Sweden (project # 14002) and LUA/ALF project, V?stra G?talandsregionen, Sweden (project # ALFGBG-11019)
NONE
The Torsten S?derberg Foundation at the royal Swedish Academy of Sciences, the Alzheimer Foundation, Sweden, the Stiftelsen f?r Gamla Tj?narinnor, Stockholm, Sweden and Hj?rnfonden, Sweden.
NONE
NONE
NONE
NONE
NONE
NONE
- For the Swedish BioFINDER study
- From the Clinical Memory Research Unit (O.H., S.J., S.H.), Department of Clinical Sciences, Lund University; Memory Clinic (O.H., S.J., S.H.), Skåne University Hospital, Sweden; UCL Institute of Neurology (N.M., A.J.L., H.Z.), Queen Square, London, UK; Clinical Neurochemistry Laboratory (R.C., H.Z., K.B.), Institute of Neuroscience and Physiology (U.A.), The Sahlgrenska Academy at University of Gothenburg, Mölndal; UmanDiagnostics (N.N.), Umeå; and Department of Pharmacology and Clinical Neuroscience (J.L., L.F.), Umeå University, Sweden.
- Correspondence to Dr. Hansson: Oskar.Hansson{at}med.lu.se
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Serum NFL discriminates Parkinson disease from atypical parkinsonismsTainá M. Marques, Anouke van Rumund, Patrick Oeckl et al.Neurology, February 27, 2019 -
Article
Neurofilament light chainA prognostic biomarker in amyotrophic lateral sclerosisChing-Hua Lu, Corrie Macdonald-Wallis, Elizabeth Gray et al.Neurology, May 01, 2015 -
Article
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosisEmily Feneberg, Patrick Oeckl, Petra Steinacker et al.Neurology, December 06, 2017 -
Article
Serum neurofilament light chain in behavioral variant frontotemporal dementiaPetra Steinacker, Sarah Anderl-Straub, Janine Diehl-Schmid et al.Neurology, September 12, 2018